Samsara Therapeutics

📍 Oxford, United Kingdom🗓 Founded 2018👥 22 employees💰 Last funded May 2021
Biotechnology Research🌐 samsaratherapeutics.com
Website LinkedIn
Samsara Therapeutics, Inc. is biopharmaceutical company aiming to discover first-in-class therapeutics that treat rare genetic and neurodegenerative disease, and extend healthy lifespan. Samsaras platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy. Samsara Therapeutics is a global biotech company with operations in Oxford and Boston and significant academic collaborations in Paris and Graz
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in Samsara Therapeutics?
Samsara Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Samsara Therapeutics last raise funding?
The most recent investment in Samsara Therapeutics recorded on gritt.io was in May 2021.
When was Samsara Therapeutics founded?
Samsara Therapeutics was founded in 2018.
What industry is Samsara Therapeutics in?
Samsara Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Samsara Therapeutics based?
Samsara Therapeutics is headquartered in Oxford, United Kingdom.